Skip to main content
OpenTrials

Clinical trial condition

Choroidal Neovascularization Secondary to Pathologic Myopia

Explore clinical trials studying Choroidal Neovascularization Secondary to Pathologic Myopia. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Choroidal Neovascularization Secondary to Pathologic Myopia trial results

Completed

A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia

NCT06176352

Conditions
Choroidal Neovascularization Secondary to Pathologic Myopia
Locations
  • Strathfield Retina Clinic Strathfield, New South Wales, Australia
  • Sydney Eye Hospital Sydney, New South Wales, Australia
  • Sydney Retina Clinic and Day Surgery Sydney, New South Wales, Australia
  • Centre For Eye Research Australia East Melbourne, Victoria, Australia
View all 62 locations
View Trial Details
Completed

A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

NCT02034006

Conditions
Choroid Diseases, Choroidal Neovascularization, Choroidal Neovascularization Secondary to Pathologic Myopia, +10 more
Locations
  • Novartis Investigative Site Ancona, AN, Italy
  • Novartis Investigative Site Bari, BA, Italy
  • Novartis Investigative Site Bologna, BO, Italy
  • Novartis Investigative Site Desenzano del Garda, BS, Italy
View all 31 locations
View Trial Details

Related conditions